Trials / Active Not Recruiting
Active Not RecruitingNCT06680466
A Phase Ⅱ Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain After Abdominal Surgery
A Multicenter, Ramdomized, Double-Blind, Dose-Regimen Finding, Placebo and Active-Controlled Phase Ⅱ Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain After Abdominal Surgery
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 179 (actual)
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Primary Objective： To explore the analgesic efficacy of YZJ-4729 compared with placebo in patients with acute postoperative pain following abdominal surgery. Secondary Objective： To explore the analgesic efficacy and safety of YZJ-4729 compared with placebo and morphine in patients with acute postoperative pain following abdominal surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YZJ-4729 | Dose Group 1 |
| DRUG | morphine | morphine, |
| DRUG | placebo | placebo |
| DRUG | YZJ-4729 | Dose Group 2 |
| DRUG | YZJ-4729 | Dose Group 3 |
| DRUG | YZJ-4729 | Dose Group 4 |
Timeline
- Start date
- 2023-12-26
- Primary completion
- 2024-07-15
- Completion
- 2024-11-01
- First posted
- 2024-11-08
- Last updated
- 2024-11-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06680466. Inclusion in this directory is not an endorsement.